| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/13/2007 | US7175997 BMP-11 compositions |
| 02/13/2007 | US7175850 Formulation for topical non-invasive application in vivo |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | CA2510981C Fibrin sealant compositions and methods for utilizing same |
| 02/08/2007 | WO2007015585A1 Agent for reduction of oxidized albumin level |
| 02/08/2007 | WO2007015567A1 Cyclic amine compound |
| 02/08/2007 | WO2007014798A2 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
| 02/08/2007 | WO2007014771A1 Stimulators of factor x activated (fxa) as new topical antihemorrhagic agents |
| 02/08/2007 | WO2006063837A3 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 02/08/2007 | WO2006052718A8 Farnesyltransferase inhibitors for treating sepsis |
| 02/08/2007 | WO2005113006A3 Use of dipyridamole for treatment of resistance to platelet inhibitors |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032538 Use of compounds |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070031441 Immunotherapy based on dendritic cells |
| 02/08/2007 | US20070031368 Chemokine conjugates |
| 02/08/2007 | CA2617534A1 Lipidated tissue factor and factor xa as a new topical anti-hemorrhagic agent |
| 02/08/2007 | CA2617256A1 Cyclic amine compound |
| 02/08/2007 | CA2616912A1 Use of the globular domain of acrp30 for the preparation of a medicament for the prevention and/or treatment of thrombosis-related diseases |
| 02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
| 02/07/2007 | EP1749537A1 Anti-idiotypics antibodies having a neutralising activity against factor VIII inhibitor antibody |
| 02/07/2007 | EP1749536A1 Activated factor X stimulants as new antihemorrhagic agents for topical use |
| 02/07/2007 | EP1748997A1 Substituted thiophene-2-carboxylic acid amides, the production thereof and the use thereof as drugs |
| 02/07/2007 | EP1748996A1 Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug |
| 02/07/2007 | EP1748985A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 02/07/2007 | EP1748760A1 Superloaded liposomes for drug delivery |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | EP1230241B1 Adenosine receptor antagonists and methods of making and using the same |
| 02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 02/07/2007 | EP1092029B1 Human thrombopoietin mutein |
| 02/07/2007 | CN1910176A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 02/07/2007 | CN1910151A Cyclic amine derivative with heteroaryl ring |
| 02/07/2007 | CN1909887A Support accumulating in injured part in vascular channel |
| 02/07/2007 | CN1907460A Externally used Chinese herbal medicinal composition |
| 02/07/2007 | CN1907449A Navel-applying medicine for treating metrorrhagia and its preparation method |
| 02/07/2007 | CN1907396A Medicine for treating cerebral hemorrhage |
| 02/07/2007 | CN1907381A Decoction preparation for treating climacteric blood heat type hysteromyoma with metrorrhagia complication and its preparation process |
| 02/07/2007 | CN1907380A Decoction preparation for treating cirrhosis ascites of XueXu type and its preparation process |
| 02/07/2007 | CN1907356A Decoction preparation for treating cirrhosis ascites of yang deficiency and its preparation process |
| 02/07/2007 | CN1907355A Decoction preparation for treating cirrhosis ascites of blood stasis type and its preparation process |
| 02/07/2007 | CN1907309A Cardiac and cerebral vascular disease treating and preventing medicinal composition |
| 02/07/2007 | CN1907302A Medicinal_foodstuff for treating climacteric menses metrorrhagia and its preparing process |
| 02/07/2007 | CN1907279A Injectio for nanometer total cambogic acid and its preparing method |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298338C Cardiovascular and cerebrovascular disease-treating medicine |
| 02/07/2007 | CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172760 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/04/2007 | CA2551317A1 Anti-idiotypic antibody neutralizing the inhibitory action of an inhibitory antibody for factor viii |
| 02/01/2007 | WO2007013842A1 Use of 4-((tert-butylimino)methyl) benzene-1,3-disulfonate n-oxide against maemorrhagic changes in the brain |
| 02/01/2007 | WO2007013841A1 Use of 4-((tert-butylimine)methyl) benzene-1,3-disulfonate n-oxide against cerebral oedema |
| 02/01/2007 | WO2007013603A1 Lymphangiogenesis promoter |
| 02/01/2007 | WO2007013588A1 Strain of turkey tail mushroom, extract from the same, and use of the same |
| 02/01/2007 | WO2007013123A1 Cyclodextrins for blood detoxification |
| 02/01/2007 | WO2005058332A3 Edestin-comprising agent for substitution of blood plasma and a method of its production |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027074 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025971 Substances causing differentiation |
| 01/31/2007 | EP1748069A1 Follistatin mutant polypeptide |
| 01/31/2007 | EP1747785A1 Cyclodextrins for blood detoxification |
| 01/31/2007 | EP1747778A1 Antifatigue composition |
| 01/31/2007 | EP1747217A1 Novel substituted thiophenecarboxamides, their production and their use as medicaments |
| 01/31/2007 | EP1747016A2 Use of dipyridamole for treatment of resistance to platelet inhibitors |
| 01/31/2007 | EP1746882A2 Methods for treating blood disorders with nitric oxide donor compounds |
| 01/31/2007 | EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 01/31/2007 | EP1200562B1 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 01/31/2007 | CN1906203A Glycosaminoglycan (GAG) mimetics |
| 01/31/2007 | CN1905889A A medical solution, a method for producing said medical solution and use thereof |
| 01/31/2007 | CN1905883A New derivatives of 6-4{4-[1h-indole-2-sulphonyl)-piperazin-1-carbonyl-phenyl]}pyradizin-3-one |
| 01/31/2007 | CN1903361A Application recombinant streptokinase for preparing medicine to treat high viscosity blood disease |
| 01/31/2007 | CN1903305A Dispersion tablets used as gynecologic hemostatic and its prepn. method |
| 01/31/2007 | CN1903294A Traditional Chinese medicine having functional of supplementing qi, disintoxication, expelling knot and harmonizing stomach, its prepn. method |
| 01/31/2007 | CN1903243A Guhong control-release tablets and prepn. method therefor |
| 01/31/2007 | CN1903241A Method for extraction and separation of pseudo-ginseng |
| 01/31/2007 | CN1903231A Ginkgo tree leave tincture |
| 01/31/2007 | CN1903221A Dispersion tablets of Naoxueking for treating cerebrovascular disease and its prepn. method |
| 01/31/2007 | CN1903206A Alprostadil freeze-dried emulsion and its prepn. method |
| 01/31/2007 | CN1903190A Furosemide injection and its prepn. method |
| 01/31/2007 | CN1903180A Freeze-dried powder injection of frusemide and its prepn. method |
| 01/31/2007 | CN1903177A Alprostadil nano-particles and its prepn. method |
| 01/31/2007 | CN1297558C 4-oxo-4,6,7,8-tetrahydro-pyrrolo[1,2-a]pyrazine-6-carboxamide compounds, preparation method thereof and pharmaceutical composition containing them |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297296C Quick acting Chinese medicine for dissolving thrombolysis and dredging collaterals and its preparation method |
| 01/31/2007 | CN1297265C Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169940 Compounds and pharmaceutical compositions comprising same |
| 01/30/2007 | US7169931 Cell differentiation, cell proliferation |
| 01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |
| 01/30/2007 | US7169899 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |